AngioDynamics Inc expected to post a loss of 14 cents a share - Earnings Preview

AngioDynamics

02/04/2024 13:40

* AngioDynamics Inc  ANGO.OQ   ANGO.O  is expected to show a
fall
in quarterly revenue when it reports  results on April 4 for the
period ending February 29 2024
    * The Latham New York-based  company is expected to report a
6.2% decrease in revenue to $75.729 million from $80.71 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for AngioDynamics Inc is for
a
loss of 14 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $14.00​, above​ its last closing price of $5.83. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Nov. 30 2023  -0.09       -0.07      -0.05     Beat    33.3
 Aug. 31 2023  -0.13       -0.13      -0.12     Beat    7.7
 May. 31 2023  0.03        0.02       0.02      Met     -11.1​
 Feb. 28 2023  -0.01       -0.01      -0.03     Missed  -300
 ​​Nov.        -0.01       -0.01      0.01      Beat    200
 30 2022                                                
 Aug. 31 2022  -0.02       -0.02      -0.06     Missed  -166.7
                                                        ​
 May. 31 2022  0.01        0.01       0.01      Met     33.3
 Feb. 28 2022  -0.01       -0.01      0.03      Beat    340
 This summary was machine generated April 2 at 12:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)